GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026)
GE HealthCare Technologies posted quarterly Net Income towards Common Stockholders of $411.0 million for Q1 2026, down 30.1% year-on-year from $588.0 million in Q1 2025, and down 31.73% on a QoQ basis from $602.0 million in Q4 2025.
GE HealthCare Technologies (GEHC) has 5 years of Net Income towards Common Stockholders data on file, last reported at $411.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 30.1% year-over-year to $411.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (down 10.42% YoY), and the FY2025 full-year result was $2.1 billion, up 4.57% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $411.0 million, down from $602.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $721.0 million in Q4 2024 and bottomed at $189.0 million in Q1 2023.
- The 5-year median for Net Income towards Common Stockholders is $464.0 million (2025), against an average of $462.2 million.
- The widest annual swing landed in 2023, when Net Income towards Common Stockholders sank 51.41%; it then soared 97.88% in 2024.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $554.0 million in 2022, then retreated by 27.26% to $403.0 million in 2023, then surged by 78.91% to $721.0 million in 2024, then slipped by 16.5% to $602.0 million in 2025, then sank by 31.73% to $411.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $411.0 million (Q1 2026), $602.0 million (Q4 2025), and $464.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 238.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 411.00 Mn |
| Dec 31, 2025 | 602.00 Mn |
| Sep 30, 2025 | 464.00 Mn |
| Jun 30, 2025 | 500.00 Mn |
| Mar 31, 2025 | 588.00 Mn |
| Dec 31, 2024 | 721.00 Mn |
| Sep 30, 2024 | 470.00 Mn |
| Jun 30, 2024 | 428.00 Mn |
| Mar 31, 2024 | 374.00 Mn |
| Dec 31, 2023 | 403.00 Mn |
| Sep 30, 2023 | 375.00 Mn |
| Jun 30, 2023 | 418.00 Mn |
| Mar 31, 2023 | 189.00 Mn |
| Dec 31, 2022 | 554.00 Mn |
| Sep 30, 2022 | 487.00 Mn |
| Jun 30, 2022 | 485.00 Mn |
| Mar 31, 2022 | 389.00 Mn |